In the last trading session, 3.65 million shares of the Ensysce Biosciences Inc (NASDAQ:ENSC) were traded, and its beta was 0.83. Most recently the company’s share price was $0.33, and it changed around -$0.02 or -5.94% from the last close, which brings the market valuation of the company to $4.96M. ENSC currently trades at a discount to its 52-week high of $2.06, offering almost -524.24% off that amount. The share price’s 52-week low was $0.14, which indicates that the current value has risen by an impressive 57.58% since then. We note from Ensysce Biosciences Inc’s average daily trading volume that its 10-day average is 79.01 million shares, with the 3-month average coming to 13.90 million.
Ensysce Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ENSC as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Ensysce Biosciences Inc is expected to report earnings per share of -0.29 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ensysce Biosciences Inc (NASDAQ:ENSC) trade information
Instantly ENSC has showed a red trend with a performance of -5.94% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.8216 on recent trading dayincreased the stock’s daily price by 59.83%. The company’s shares are currently down -68.60% year-to-date, but still up 61.55% over the last five days. On the other hand, Ensysce Biosciences Inc (NASDAQ:ENSC) is 15.56% up in the 30-day period. We can see from the shorts that 0.11 million shares have been sold at a short interest cover period of 0.31 day(s).
Ensysce Biosciences Inc (ENSC) estimates and forecasts
Ensysce Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -43.88 percent over the past six months and at a 69.51% annual growth rate that is well above the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 66.70% in revenue this quarter, and will report an increase of 81.80% in the next quarter. The year-over-year growth rate is expected to be -52.90%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 250k in revenue for the current quarter. 2 analysts expect Ensysce Biosciences Inc to make 240k in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at -53.40%.
ENSC Dividends
Ensysce Biosciences Inc’s next quarterly earnings report is expected to be released in November.
Ensysce Biosciences Inc (NASDAQ:ENSC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.17% of Ensysce Biosciences Inc shares, and 3.35% of them are in the hands of institutional investors. The stock currently has a share float of 3.39%. Ensysce Biosciences Inc stock is held by 11.0 institutions, with PLANTE MORAN FINANCIAL ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 0.0004% of the shares, which is about 20.0 shares worth $10.0.
